Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 652.96 +4.96 (+0.77%)
As of 04:13 AM Eastern

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
652.96
656.02
50-Day Range
562
658
52-Week Range
480
736
Volume
1,101 shs
Average Volume
91,627 shs
Market Capitalization
£234.55 million
P/E Ratio
6.23
Dividend Yield
4.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
UK firms fear tougher employment regulation, CBI says
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 682 at the beginning of the year. Since then, IBT shares have decreased by 3.8% and is now trading at GBX 656.02.

International Biotechnology (LON:IBT) issued its quarterly earnings results on Tuesday, May, 13th. The company reported ($5.60) earnings per share for the quarter. International Biotechnology had a trailing twelve-month return on equity of 13.67% and a net margin of 90.66%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Last Earnings
5/13/2025
Today
8/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 104.80
Trailing P/E Ratio
6.18
Forward P/E Ratio
686.74
P/E Growth
N/A
Net Income
£37.91 million
Net Margins
90.66%
Pretax Margin
N/A
Return on Equity
13.67%
Return on Assets
3.57%

Debt

Debt-to-Equity Ratio
8.09
Current Ratio
N/A
Quick Ratio
0.32

Sales & Book Value

Annual Sales
£41.82 million
Price / Sales
5.57
Cash Flow
GBX 4.16 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
35,921,299
Free Float
N/A
Market Cap
£232.77 million
Optionable
Not Optionable
Beta
0.21
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:IBT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners